Indrayani Biotech Receives BSE Listing Approval for 8.36 Million Rights Issue Shares
Indrayani Biotech Ltd 路 Rights Issue 路 06 Nov 2026, 8:09 pm
Indrayani Biotech Receives BSE Listing Approval for 8.36 Million Rights Issue Shares Indrayani Biotech Limited received listing approval from BSE Limited on 6th Nov'26 for 83,64,036 equity shares of face value Rs. 10/- each (partly paid-up at Rs. 3.75/- each) issued pursuant to its rights issue. Trading permission for the newly issued securities will be granted following depository confirmation regarding share credits to beneficiary accounts and submission of the trading approval application within seven working days in compliance with SEBI ICDR regulations.
Original exchange filing (PDF)
More announcements from Indrayani Biotech Ltd
- Annual Report of the Company for the Financial year ended March 31, 2026. 路 07 Nov 2026
- Annual Report of the Company for the Financial year ended March 31, 2026. 路 07 Nov 2026
- Submission of Notice of the 34th Annual General Meeting will be held on November 30, 2026 at 03.00 PM IST through VC/OAVM 路 07 Nov 2026
- Intimation of Record date for the 34th Annual General Meeting 路 07 Nov 2026
- Revised outcome of the Rights Issue Committee held on November 03, 2026 路 04 Nov 2026
- Outcome of the Rights Issue Committee Meeting held on November 03, 2026 路 03 Nov 2026
- Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve 1. Notice of the 34th Annual .... 路 03 Nov 2026
- Appointment of Ms. Nattery Srinivasan Poornima, Company Secretary in Practice, as the Secretarial Auditor of the Company. 路 02 Nov 2026
